These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12408340

  • 1. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.
    Villari D, Caruso R, Grosso M, Vitarelli E, Righi M, Barresi G.
    Pathology; 2002 Oct; 34(5):423-6. PubMed ID: 12408340
    [Abstract] [Full Text] [Related]

  • 2. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections.
    Fan Z, van de Rijn M, Montgomery K, Rouse RV.
    Mod Pathol; 2003 Feb; 16(2):137-44. PubMed ID: 12591966
    [Abstract] [Full Text] [Related]

  • 3. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.
    Maitra A, Murakata LA, Albores-Saavedra J.
    Am J Clin Pathol; 2001 May; 115(5):689-94. PubMed ID: 11345832
    [Abstract] [Full Text] [Related]

  • 4. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD, Rege JD, Joshi AS, Vaiphei K, Amarapurkar DN.
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [Abstract] [Full Text] [Related]

  • 5. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma.
    Leong AS, Sormunen RT, Tsui WM, Liew CT.
    Histopathology; 1998 Oct; 33(4):318-24. PubMed ID: 9822920
    [Abstract] [Full Text] [Related]

  • 6. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
    Chu PG, Ishizawa S, Wu E, Weiss LM.
    Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
    [Abstract] [Full Text] [Related]

  • 7. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
    Zhao M, Sun L, Lai JZ, Shi H, Mei K, He X, Jin X, Lai J, Cao D.
    Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
    Wang HL, Lu DW, Yerian LM, Alsikafi N, Steinberg G, Hart J, Yang XJ.
    Am J Surg Pathol; 2001 Nov; 25(11):1380-7. PubMed ID: 11684954
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical characterization of canine intestinal epithelial and mesenchymal tumours with a monoclonal antibody to hepatocyte paraffin 1 (Hep Par 1).
    Ramos-Vara JA, Miller MA.
    Histochem J; 2002 Nov; 34(8-9):397-401. PubMed ID: 12814187
    [Abstract] [Full Text] [Related]

  • 10. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
    Hanif R, Mansoor S.
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
    [Abstract] [Full Text] [Related]

  • 11. Glypican-3 is useful but not superior to Hep Par 1 in differentiating hepatocellular carcinoma from other liver tumours.
    Pour AM, Masir N, Rose IM.
    Malays J Pathol; 2016 Dec; 38(3):229-233. PubMed ID: 28028292
    [Abstract] [Full Text] [Related]

  • 12. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma.
    Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ.
    Am J Clin Pathol; 2003 Mar; 119(3):361-6. PubMed ID: 12645337
    [Abstract] [Full Text] [Related]

  • 13. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
    Terracciano LM, Glatz K, Mhawech P, Vasei M, Lehmann FS, Vecchione R, Tornillo L.
    Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391
    [Abstract] [Full Text] [Related]

  • 14. Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer.
    Baldus SE, Zirbes TK, Glossmann J, Fromm S, Hanisch FG, Mönig SP, Schröder W, Schneider PM, Flucke U, Karsten U, Thiele J, Hölscher AH, Dienes HP.
    Oncology; 2001 Oct; 61(2):147-55. PubMed ID: 11528254
    [Abstract] [Full Text] [Related]

  • 15. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR.
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [Abstract] [Full Text] [Related]

  • 16. Gastric mucous neck cell and intestinal goblet cell phenotypes in gastric adenocarcinoma.
    Hughes NR, Bhathal PS.
    J Clin Pathol; 1997 Sep; 50(9):741-8. PubMed ID: 9389974
    [Abstract] [Full Text] [Related]

  • 17. Does Hepatocyte Paraffin 1 expression stand a role in determining the site origin of an adenocarcinoma from unknown gastrointestinal primary?
    Yadav R, Chopra S, Garg A, Gupta B, Kinra P, Gupta SD, Das P.
    Indian J Pathol Microbiol; 2016 Sep; 59(4):474-480. PubMed ID: 27721277
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte expressions in hepatocellular carcinomas, gastrointestinal neoplasms, and non-neoplastic gastrointestinal mucosa: its role as a diagnostic marker.
    Lee HS, Kim WH, Kang GH.
    J Korean Med Sci; 2003 Dec; 18(6):842-8. PubMed ID: 14676441
    [Abstract] [Full Text] [Related]

  • 19. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
    Carleton C, Hoang L, Sah S, Kiyokawa T, Karamurzin YS, Talia KL, Park KJ, McCluggage WG.
    Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
    [Abstract] [Full Text] [Related]

  • 20. p62 Expression in primary carcinomas of the digestive system.
    Qian HL, Peng XX, Chen SH, Ye HM, Qiu JH.
    World J Gastroenterol; 2005 Mar 28; 11(12):1788-92. PubMed ID: 15793865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.